Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90 ...

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

The cornea is the clear, outermost layer of the eye. Its outer border, the limbus, contains a large volume of healthy stem ...

Whatever you do, don’t call it a festival. There’s no set schedule or events during the two-day gathering, warns Dave Shenkman, owner of Kite Connection on the Huntington Beach Pier and ...

A subsidiary of Gilead Sciences, Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered ...

A federal judge last week dismissed the claims against an Avon police sergeant who transported a suicidal man to the Eagle County jail, as part of a broader lawsuit over the man's death in custody.

Valued at a market cap of $143.8 billion, Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need.

The ABC Kite Fest returns for its 97th year with the classic kite showcase and kite contest, MossFest children’s concert, High Flyer VIP club and more "For almost 100 years, Austinites have ...

In addition to its therapeutic advancements, Gilead has made major strides in oncology and cell therapies with innovative products like Kite Pharma's Yescarta, an FDA-approved CAR T-cell therapy for ...